ArticleThe Journal of physiology1996
Nifedipine-sensitive intramembrane charge movement in Purkinje cells from mouse cerebellum.
Article in The Journal of physiology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 10 citations in OpenAlex.
- Differential plasma membrane targeting of voltage-dependent calcium channel subunits expressed in a polarized epithelial cell line.The Journal of physiology · 1999Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1. The intramembrane charge movement was recorded in freshly dissociated Purkinje cells from 14- to 18-day-old mouse cerebellum using the whole-cell voltage clamp technique. 2. After pharmacological elimination of all ionic currents, a depolarizing pulse from a holding potential of -80 mV revealed a transient capacitive outward current at the onset and a transient inward current at the end of the pulse. The amount of charge transferred at the onset (Qon) was equivalent to that moved at the end of the pulse (Qoff). The decay time course of Qon can be fitted by a single exponential curve with a maximum time constant of 1.89 +/- 0.35 ms at 20 mV (n = 11). 3. The charge movement had an S-shaped dependence on test membrane potential, according to a two-state Boltzmann function. The maximum amount (Qmax) of Qon that could be moved was 17.46 +/- 0.83 nC muF-1; the membrane potential at which half the charge movement occurred (V) was 13.48 +/- 2.20 mV and the slope factor (k) was 16.83 +/- 0.84 mV (n = 27). 4. Phenylglyoxal (2 mM), an arginine-specific modifying reagent, reduced Qmax to 60% of control after 20 min treatment. 5. The charge movement was partially immobilized by nifedipine in a dose-dependent manner with an IC50 of 70 nM. The fraction of the nifedipine-sensitive component was 39% of the total charge movement. The potential dependence of the nifedipine-sensitive charge movement could be expressed by a Boltzmann function with values of 7.00 +/- 0.53 nC muF-1 for Qmax, 31.44 +/- 4.23 mV for V and 21.53 +/- 3.18 mV for k (n = 8). 6. The P-type calcium channel specific inhibitor, omega-Aga IVA (250 nM), had no effect on intramembrane charge movement. 7. The above results show that part of the intramembrane charge movement in Purkinje cells may be related to a conformational change of DHP receptors upon membrane depolarization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.